• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development

    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    ENDRA Life Sciences Issued 27th Patent

    AI-Enabled SKOUT Device Improves Colorectal Cancer Screening

    Simon Johnson Appointed as Senior Business Development VP at MedAcuity

    Foster Corporation Named Marketing Partner for AdvanSource Biomaterials

    Researchers Develop New Apparatus for the Treatment of Cardiovascular Diseases
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development

    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Theranos Fraud Trial, Part II: The Blame Game Continues

    An Update on Surgical Robotics

    Letting the Light In: How Failure Analysis is the Cornerstone of Success

    Three Talent Strategies to Attract High-Demand Skills

    The Advantages of Bioburden Screening for Sterilization Validation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Cirtec Medical

    Xact Wire EDM Corp.

    Fusion Biotec Inc.

    BMP Medical

    Trademark Plastics Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    ‘Right to Repair’: Separating Fact from Fiction

    Taking a Holistic Approach to Decentralized Clinical Trials (DCTs)

    Investment in Health Startups Drops

    The Power of Leveraging Customer Relationships

    Cost Effective & Efficient Wire EDM Techniques
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Cirtec Medical

    Xact Wire EDM Corp.

    Fusion Biotec Inc.

    BMP Medical

    Trademark Plastics Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    QIAGEN's QIAstat-Dx Syndromic Testing System Wins FDA Nod

    Molecular diagnostic testing for accurate insights on hard-to-diagnose syndromes, initial launch with respiratory panel for detection of over 20 pathogens.

    QIAGEN
    QIAstat-Dx delivers the precision of molecular testing to identify hard-to-diagnose respiratory infections, which sicken millions of U.S. patients each year and kill tens of thousands.
    Related CONTENT
    • Roche to Acquire Long-Term Partner TIB Molbiol
    • Abbott's Panbio Rapid COVID-19 Antigen Self-Test Earns EU Approval
    • QIAGEN Launches Technology to Triple COVID-19 Lab Testing Capacity
    • Paige Appoints Chief Commercial Officer and Medical Director
    • QIAGEN Granted EUA for its 4-Plex COVID-19 Test
    QIAGEN05.20.19
    QIAGEN N.V. announced the U.S. launch of its QIAstat-Dx syndromic testing system after receiving 510(k) clearance by the U.S. Food and Drug Administration, along with the multiplex QIAstat-Dx Respiratory Panel for simultaneous qualitative detection and identification of multiple respiratory viral and bacterial pathogens.
     
    QIAstat-Dx (formerly Stat-Dx DiagCORE) represents the next-generation in multiplex molecular diagnostic systems that enables fast, cost-effective and flexible syndromic testing with novel Sample to Insight solutions powered by QIAGEN chemistries. The system, based on the proprietary DiagCORE technology, received CE-IVD marking in January 2018 and already has a significant installed base.
     
    QIAstat-Dx is being launched in the U.S. with a comprehensive respiratory panel that detects more than 20 pathogens. The panel is the first test in a deep and broad pipeline of planned assays for QIAstat-Dx in the U.S., with plans to launch a gastrointestinal panel later in 2019. With the ability to multiplex as high as 48 targets, a deep pipeline is planned that will span infectious diseases, oncology, companion diagnostics, and other disease areas.
     
    Demand for syndromic testing with molecular diagnostics is growing rapidly, to accurately evaluate infections and other diseases that manifest as a set of symptoms with uncertain causes. According to the U.S. Centers for Disease Control (CDC), as many as 35 million cases of influenza each year lead to several hundred thousand hospitalizations and as many as 56,000 deaths in the U.S.. The CDC uses estimates of flu cases because most respiratory infections are not diagnosed or reported with precision as part of the agency’s disease surveillance system. In respiratory syndromes and flu testing, QIAGEN estimates the total addressable market at about 1.5 million tests per year in the United States.
     
    “QIAstat-Dx delivers the precision of molecular testing to identify hard-to-diagnose respiratory infections, which sicken millions of U.S. patients each year and kill tens of thousands. We are pleased to roll out the QIAstat-Dx Respiratory Panel for healthcare providers as they begin to prepare for the 2019-20 flu season,” said Thierry Bernard, Senior Vice President and Head of Molecular Diagnostics for QIAGEN. “DiagCORE has been enthusiastically received in Europe and other regions of the world for its rapid, clear insights in clinics and other near-patient settings, as well as its cost-efficiency. We now look forward with the launch of QIAstat-Dx to similar success in the U.S. QIAstat-Dx will provide physicians with results to aid in the appropriate diagnosis and treatment for each patient. We are developing a deep menu of additional multiplex panels, such as tests for gastrointestinal syndromes and meningitis infections.”
     
    QIAstat-Dx significantly improves syndromic testing workflows for customers:
     
    • Powerful capabilities—QIAGEN sample and assay technologies deliver true Sample to Insight evaluation with real-time PCR (polymerase chain reaction).
    • Ease of use—A lab technician loads a clinical sample into a single-use QIAstat-Dx cartridge and places it in the analyzer, requiring less than one minute of hands-on time. Sample processing is built in, all reagents are on-board, and the technician’s workflow is intuitive.
    • Speed—QIAstat-Dx is designed to operate in a range of near-patient clinical settings, eliminating the delay of sending samples to a centralized laboratory. Results are available in about one hour.
    • Cost-efficiency—QIAstat-Dx cartridges offer significantly lower costs compared to other systems, a benefit for healthcare providers in the current reimbursement landscape. Connectivity and bi-directional integration into laboratory information systems add further efficiencies.
    • Flexibility—Cartridges are processed in a scalable, proprietary and fully integrated platform that can be configured from one to four modules, depending on the volume needed. QIAstat-Dx is designed for an expanding test menu in the future with the potential ability to process up to 48 targets simultaneously. 

    QIAGEN will demonstrate the QIAstat-Dx system and its capabilities at these upcoming U.S. conferences:
     
    • American Society of Microbiology (ASM)—June 20-24, San Francisco, Calif.
    • American Association of Clinical Chemistry (AACC)—August 4-8, Anaheim, Calif.
     
    The QIAstat-Dx Respiratory Panel is a multiplexed nucleic acid test that evaluates nasopharyngeal swabs obtained from individuals suspected of respiratory tract infections. The following pathogens and subtypes are identified using the QIAstat-Dx Respiratory Panel: Adenovirus, Coronavirus 229E, Coronavirus HKU1, Coronavirus NL63, Coronavirus OC43, Human Metapneumovirus A+B, Influenza A, Influenza A H1, Influenza A H3, Influenza A H1N1/pdm09, Influenza B, Parainfluenza Virus 1, Parainfluenza Virus 2, Parainfluenza Virus 3, Parainfluenza Virus 4, Rhinovirus/Enterovirus, Respiratory Syncytial Virus A+B, Bordetella pertussis, Chlamydophila pneumoniae and Mycoplasma pneumoniae.
    Related Searches
    • market
    • detection
    • diagnosis
    • test
    Related Knowledge Center
    • Diagnostics
    Suggested For You
    Roche to Acquire Long-Term Partner TIB Molbiol Roche to Acquire Long-Term Partner TIB Molbiol
    Abbott Abbott's Panbio Rapid COVID-19 Antigen Self-Test Earns EU Approval
    QIAGEN Launches Technology to Triple COVID-19 Lab Testing Capacity QIAGEN Launches Technology to Triple COVID-19 Lab Testing Capacity
    Paige Appoints Chief Commercial Officer and Medical Director Paige Appoints Chief Commercial Officer and Medical Director
    QIAGEN Granted EUA for its 4-Plex COVID-19 Test QIAGEN Granted EUA for its 4-Plex COVID-19 Test
    CerTest Biotec & BD Add Saliva to the Visasure SARS-CoV-2 Detection Kit CerTest Biotec & BD Add Saliva to the Visasure SARS-CoV-2 Detection Kit
    DiaSorin to Buy Luminex for $1.8B DiaSorin to Buy Luminex for $1.8B
    Hologic Buys Molecular Dx Firm Diagenode for $159M Hologic Buys Molecular Dx Firm Diagenode for $159M
    Rapid Medical Diagnostic Kits Market Size Worth $23.04 Billion By 2027 Rapid Medical Diagnostic Kits Market Size Worth $23.04 Billion By 2027
    Hologic to Buy Cancer Test Maker Biotheranostics for $230M Hologic to Buy Cancer Test Maker Biotheranostics for $230M
    Company Developing a COVID-19 Severity Risk Test for U.S. Government Company Developing a COVID-19 Severity Risk Test for U.S. Government
     How COVID-19 is Reshaping the Diagnostics Testing Sector How COVID-19 is Reshaping the Diagnostics Testing Sector
    QIAGEN Fully Acquires NeuMoDx for $248M QIAGEN Fully Acquires NeuMoDx for $248M
    QIAGEN to Launch Digital, Portable COVID-19 Antibody Test QIAGEN to Launch Digital, Portable COVID-19 Antibody Test
    Thermo Fisher Terminates $11.5B QIAGEN Deal Thermo Fisher Terminates $11.5B QIAGEN Deal

    Related Breaking News

    • Diagnostics
      Roche to Acquire Long-Term Partner TIB Molbiol

      Roche to Acquire Long-Term Partner TIB Molbiol

      Expands PCR-test portfolio in the fight against new infectious diseases.
      GlobeNewswire 09.09.21

    • Diagnostics
      Abbott

      Abbott's Panbio Rapid COVID-19 Antigen Self-Test Earns EU Approval

      Approved for sale directly to consumers and for use in adults and children with or without symptoms.
      Abbott Laboratories 06.28.21

    • QIAGEN Launches Technology to Triple COVID-19 Lab Testing Capacity

      QIAGEN Launches Technology to Triple COVID-19 Lab Testing Capacity

      The innovation integrates sample preparation and detection in a single kit, enabling throughput of more than 670 tests per PCR cycler in an eight-hour shift.
      Business Wire 06.15.21


    • Paige Appoints Chief Commercial Officer and Medical Director

      Paige Appoints Chief Commercial Officer and Medical Director

      Andy Moye has worked in molecular diagnostics, biotechnology and life sciences.
      Michael Barbella, Managing Editor 05.10.21

    • QIAGEN Granted EUA for its 4-Plex COVID-19 Test

      QIAGEN Granted EUA for its 4-Plex COVID-19 Test

      The assay can detect and differentiate influenzas A and B, respiratory syncytial virus (RSV), and COVID-19 infections within 80 minutes.
      Michael Barbella, Managing Editor 05.06.21

    Loading, Please Wait..

    Trending
    • Siemens Healthineers & The Ohio State University Wexner Medical Center Enter Strategic Partnership
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • How To Overcome The Top 6 Medical Device Manufacturing Challenges
    • ‘Right To Repair’: Separating Fact From Fiction
    • The Future Of Biomedical Engineering Advancements
    Breaking News
    • ENDRA Life Sciences Issued 27th Patent
    • AI-Enabled SKOUT Device Improves Colorectal Cancer Screening
    • Simon Johnson Appointed as Senior Business Development VP at MedAcuity
    • Foster Corporation Named Marketing Partner for AdvanSource Biomaterials
    • Researchers Develop New Apparatus for the Treatment of Cardiovascular Diseases
    View Breaking News >
    CURRENT ISSUE

    June 2022

    • OEMs Seek Molders Offering Timely Techniques
    • Robotic Surgery: Cutting Through to the Latest
    • Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Pharmavite Expands in Ohio with $200 Million Investment
    Nestlé Health Science Expands in New Zealand with Deal to Buy The Better Health Company
    Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products
    Coatings World

    Latest Breaking News From Coatings World

    Clariant’s Launches Dispersogen Flex 100
    Lincoln Tech Enters Partnership with AkzoNobel
    AkzoNobel Launches International Interzone 945GF
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    ENDRA Life Sciences Issued 27th Patent
    AI-Enabled SKOUT Device Improves Colorectal Cancer Screening
    Simon Johnson Appointed as Senior Business Development VP at MedAcuity
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Takeda to Expand U.S. Footprint
    Croda Pharma's Lipid Systems Capability to Support mRNA Vaccines
    WuXi STA Opens High-Potency API Plant
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Latest Updates About Cosmoprof North America
    Meet the Clean Beauty Brand for Dogs
    Paco Rabanne Introduces Elle Fanning as Ambassador for New ‘Fame’ Fragrance
    Happi

    Latest Breaking News From Happi

    Two-Part Skincare Product Patented by Estée Lauder Companies
    American Cleaning Institute Pens Letter to Congress Encouraging Examination of Recyclability Improvements
    The Expert Panel for Fragrance Safety Celebrates 55 Years
    Ink World

    Latest Breaking News From Ink World

    INX Launches INXFlex Contour for Shrink Sleeve Market
    Xerox Announces Unexpected Passing of Vice Chairman and CEO John Visentin
    MNYPIA Golf Outing Set to Tee Off on Aug. 17
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Meyers purchased by third generation of Dillon family
    Epson now shipping ColorWorks C4000 inkjet label printer
    Nobelus launches new films for prime labels
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    What You’re Reading on Nonwovens-Industry.com
    Daio, Livedo Partner to Recycle Diapers
    Suominen Launches Hydraspun Reserve
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    3D Systems and EMS-GRILTECH Enter Strategic Partnership
    AIP Researchers Develop Microfluidic-Based Soft Robotic Prosthetic
    David Sharp Named Global Marketing VP at Catalyst OrthoScience
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Impinj Launches E910 RFID Reader Chip for Next Generation Enterprise IoT
    onsemi Receives Recognition for Sustainability for Third Straight Year
    Xerox Announces the Unexpected Passing of Vice Chairman and CEO John Visentin

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login